Skip to content

Comparison of Crestal Bone Loss Around Dental Implants with and without recombinant human bone morphogenetic protein Coating: A CBCT Study

Comparative evaluation of crestal bone loss around dental implant with and without coating of Recombinant Human Bone Morphogenic Protein-2 (rhBMP-2): A Clinico Radiographic CBCT study - Nil

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087474
Enrollment
20
Registered
2025-05-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K068- Other specified disorders of gingiva and edentulous alveolar ridge

Interventions

Intervention1: Implant with rhBMP2: The Implant will be coated with rhBMP-2 at the time of placement. Control Intervention1: Implant only: The Implant will not be coated with rhBMP-2

Sponsors

Dr Anuradha Mehra
Lead Sponsor
Dr Soundarya Singh
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having single missing tooth with an adequate width and height of edentulous space available for placement of implant. 2. Edentulous sites in mandibular and maxillary arches. 3. Adjacent teeth intact; restored with functionally & esthetically good restorations; restored with prosthesis precluding the addition of the missing tooth. 4. Patients with good periodontal and general health.

Exclusion criteria

Exclusion criteria: 1. Patients who are unable to perform routine oral hygiene procedures. 2. Patients with history of smoking. 3. Patients with TMJ disorders. 4. Patients with dental history of bruxism and parafunctional habits or deep bite cases. 5. History of substance abuse. 6. Insufficient vertical inter arch space to accommodate the prosthodontic components available, together with a proposed pontic and occasional gingival analogue designs. 7. Patients with uncontrolled diabetes. 8. Absence of opposing occlusion.

Design outcomes

Primary

MeasureTime frame
Crestal Bone Loss Around Dental ImplantsTimepoint: At Baseline 4 Months 9 Months

Secondary

MeasureTime frame
Soft Tissue Changes Around The Dental ImplantTimepoint: At Baseline 4 Months 9 Months

Countries

India

Contacts

Public ContactDr. Anuradha Mehra

Surbharti Dental College And Hospital

singhsoundarya@gmail.com8383062129

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026